Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Abe

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Frontiers in Cell and Developmental Biology|September 24, 2019
The Golgin Protein Giantin Regulates Interconnections Between Golgi StacksAyano Satoh, Mitsuko Hayashi-Nishino, Takuto Shakuno, et al.
Molecular Cancer Therapeutics|May 12, 2018
TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion MutationsShinichi Hasako, Miki Terasaka, Naomi Abe, et al.
Cell Death Discovery|May 16, 2018
The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomasMakoto Miyazaki, Ryo Otomo, Yuko Matsushima-Hibiya, et al.
Molecular Cancer Research : MCR|August 31, 2019
TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> MutationsHibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, et al.
The Journal of Trauma and Acute Care Surgery|April 2, 2026
Development of a neurologic deterioration risk score in pediatric mild traumatic brain injury and intracranial injuriesPradip P Chaudhari, Susan Durham, Jose Pineda, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Frontiers in Cell and Developmental Biology|September 24, 2019
The Golgin Protein Giantin Regulates Interconnections Between Golgi StacksAyano Satoh, Mitsuko Hayashi-Nishino, Takuto Shakuno, et al.
Molecular Cancer Therapeutics|May 12, 2018
TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion MutationsShinichi Hasako, Miki Terasaka, Naomi Abe, et al.
Cell Death Discovery|May 16, 2018
The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomasMakoto Miyazaki, Ryo Otomo, Yuko Matsushima-Hibiya, et al.
Molecular Cancer Research : MCR|August 31, 2019
TAS6417/CLN-081 Is a Pan-Mutation-Selective EGFR Tyrosine Kinase Inhibitor with a Broad Spectrum of Preclinical Activity against Clinically Relevant <i>EGFR</i> MutationsHibiki Udagawa, Shinichi Hasako, Akihiro Ohashi, et al.
The Journal of Trauma and Acute Care Surgery|April 2, 2026
Development of a neurologic deterioration risk score in pediatric mild traumatic brain injury and intracranial injuriesPradip P Chaudhari, Susan Durham, Jose Pineda, et al.
Pageof 4